Delivery Order SPE2DR25D1017-SPE2DR26F9BWL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,340.08 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,607.96 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. This competitively awarded, non-set-aside contract was issued on December 15, 2025, with an ultimate completion date of December 16, 2025, and represents a firm fixed price delivery order for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,038.15 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This competitive award, issued on September 29, 2025, with an ultimate completion date of September 30, 2025, represents a firm fixed price transaction for pharmaceutical supply to support federal medical procurement needs. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.59 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This was a competitively awarded, non-set-aside firm fixed price contract with an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,211.75 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. This firm fixed price, non-competitive delivery order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The order was fulfilled at the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.30 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This competitively awarded, firm fixed-price delivery order was issued on April 30, 2025, with an ultimate completion date of May 1, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters and serves as a major vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.04 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens, with an ultimate completion date of December 4, 2025. This non-competitive delivery order was issued under a firm fixed price arrangement and represents a single pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,749.44 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL insulin pens (3 mL). The award, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency has awarded a $2,345.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This competitively awarded, non-set-aside contract was issued on December 19, 2025, with an ultimate completion date of December 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for $2,491.38 to supply Tresiba FlexTouch 200 unit/mL 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BWLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,340.08 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This competitive award, issued on December 19, 2025, with completion targeted for December 22, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery order from its corporate office location in the same municipality, leveraging its extensive experience supplying pharmaceutical products to federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award demonstrates AmerisourceBergen Drug Corp's critical role in the federal medical supply chain, serving Defense Health Agency requirements and other government healthcare systems through flexible contracting mechanisms that support broad therapeutic needs across military and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/18/25 |